The CKD summit of the International Society of Nephrology (July 2016) concluded that strong systems-based approaches to preventing and detecting AKI early are needed, and that risk factors at the regional level should be identified. 16 Accordingly, we investigated the epidemiology of AKI events in a region with a large Indigenous Australian population, with the aim of identifying opportunities for reducing the high incidence of CKD among Aboriginal and Torres Strait Islander Australians.
Methods
We employed a retrospective population-based study design. Cases of AKI during the period 1 June 2009 -30 May 2016 were identified in data extracted from Kimberley electronic medical record systems (MMEx, ISA Healthcare; Communicare, HealthConnex). The analysis included data for all individuals documented as being Aboriginal or Torres Strait Islander Australians, aged 15 years or more at the time of renal function testing, not having end-stage kidney disease, and for whom at least two serum creatinine level values were recorded within 7 days of one another (Box 1).
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Setting
The Kimberley region is very remote and has a relatively large Indigenous Australian population (2016: 14 299 people, 42% of the total population). 17 Acute dialysis is not available in the region, and there is no intensive care unit. The nearest nephrology services are in Perth (more than 2000 km away) and Darwin (over 800 km away). CKD rates are high, and the regional capacity for satellite dialysis (120 patients) is insufficient; at the time of writing, 25 patients are in Perth on waiting lists for dialysis in the Kimberley.
Acute kidney injury events AKI events were identified as defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria:
5 an absolute increase in serum creatinine level within 48 hours of at least 26.5 μmol/L, or a relative increase within 7 days of at least 50%. AKI events were confirmed by manual review of electronic medical records. To estimate baseline CKD stage, the estimated glomerular filtration rate (eGFR) value prior to the AKI event was calculated from creatinine values with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. 18 AKI events were excluded from our analysis if they were dated after the onset of endstage kidney disease (defined by three consecutive eGFR values below 15 mL/min/1.73m 2 over at least 6 months) or the commencement of renal replacement therapy (including haemodialysis, peritoneal dialysis, or renal transplantation).
Data collection and analysis
Principal and additional diagnoses were obtained from discharge summaries, or from primary care medical records when there was no hospital admission or the discharge summary was not available. If no diagnosis was defined as the principal diagnosis, the first diagnosis was deemed the principal diagnosis. Diagnoses were categorised by ICD-10 codes and cross-checked by two authors. Discharge summaries were assessed for recording of prior CKD and of AKI as a principal or additional diagnosis.
Creatinine values and test dates were imported into Excel 2010 (Microsoft) for analysis. Descriptive statistical analysis was completed in Stata 14 (StataCorp). Population data from the 2016 census were used for calculating age-specific AKI rates for the entire audit, as the Kimberley Indigenous population was stable during this period. 17 Age groups were aggregated to match those in the AIHW AKI review; 2 95% confidence intervals (CIs) for crude rates were calculated as the standard error × 1.96. 
Ethics approval
Results
Data for 324 AKI events in 260 people were identified (Box 2). Two hundred and fifteen individuals (83%) had single events, 32 (12%) had two, nine (3%) had three, three (1%) had four, and one (0.3%) had six events. The overall AKI rate was 323 per 100 000 population (95% CI, 281-367 per 100 000 population; for people aged 15 years or more: 479 per 100 000 population; 95% CI, 427-532 per 100 000 population 
Hospitalisations and discharge summary content
Two hundred and seventy nine of 294 events for which the hospitalisation status was available (95%) were associated with a hospital admission; for 54 of the 279 events (19%), the patients were transferred to a tertiary centre, including four who underwent acute dialysis. The date of admission was available for 230 events; 78 events (34%) were detected on or before the day of admission (Box 3).
Of the 224 events for which discharge summaries were available, AKI was coded as the principal or first diagnosis for 18 events (8%) and as a secondary diagnosis for 43 events (19%); a history of CKD was recorded for 105 events (47%). Eighty-three of 224 events (37%) were in patients without CKD diagnoses in their discharge summaries and who had eGFR values exceeding 60 mL/min/1.73m 2 prior to the AKI.
Principal and additional diagnoses
A diagnosis was available for 289 of the 324 events (89%). For 88 of these 289 events (30%) a single diagnosis was recorded or the principal diagnosis was documented; for 201 events the first diagnosis listed was accepted as the principal diagnosis and others as additional diagnoses. The three most frequent ICD-10 diagnostic categories were diseases of the respiratory tract (60 of 324 events, 18%), the skin and subcutaneous tissues (41 events, 13%), and the urogenital tract (33 events, 10%); the most frequent specific diagnoses were pneumonia (39 events, 12%), infections of the skin and subcutaneous tissue (33 events, 10%), and urinary tract infections (25 events, 7.7%) (Box 5). Overall, 149 of 289 principal diagnoses (52%) were infectious in nature, and for a further 19 events (7%) an infective diagnosis was listed as an additional diagnosis (data not shown).
Discussion
We report the first population-based study in which AKI events were identified in the medical records of an Australian cohort by applying the KDIGO criteria, and the first study to examine the epidemiology of AKI in a cohort of Indigenous Australians. The age distribution of events and the pattern of associated diagnoses differed from those for the broader Australian population as recorded in the National Hospital Morbidity Database.
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Although differences in methodology prevent direct comparison of age-specific AKI rates, the age distribution of events among Indigenous Australians in the Kimberley differed from that for Australians in general; in particular, more than onequarter of events were in people under 45 years of age, compared with 8% 2 for all Australians. The higher AKI rates in younger age groups mirror the higher incidence of end-stage kidney disease among younger Indigenous Australians. 19 The AKI rates for Kimberley Indigenous people over 65 years of age were, in contrast, lower than the corresponding national rates, possibly reflecting a healthy survivor effect, a cohort effect, an increased likelihood of random error because of the small numbers of Kimberley Indigenous people in these age groups, or less frequent renal function testing of Indigenous people who are over 65.
We found that skin infections were among the most frequent principal diagnoses for Indigenous people in the Kimberley with an AKI event; in the national data, in contrast, the top ten diagnostic categories of principal diagnoses for hospitalisations in which AKI was an additional diagnosis did not include skin conditions.
2 A large burden of skin disease in Indigenous Australians has been reported, but mainly in children; [20] [21] [22] we found that the negative impact of skin infections extends into adulthood. Indigenous communities with housing problems and overcrowding as environmental risk factors are more likely to report skin conditions as health problems, 23 and streptococcal skin infections are associated with acute post-infectious glomerulonephritis and CKD. 24 The association between infections and AKI in our study reinforces the importance of addressing the underlying environmental and economic determinants of health, and of reducing barriers to identifying and treating infections in a timely manner. 25 This will require coordinating the activities of environmental health organisations, primary care bodies, and hospitals. 16 When implementing such strategies, it is important to note that one-third of events in our study were detected before or on the day of hospital admission, indicating that AKI can be prevented and identified in community as well as in hospital settings.
As risk factors for AKI (including proteinuria and pre-existing CKD 26 ) are common among Indigenous Australians, 2 awareness a mong doctors of the substantial proportion of people at high risk for AKI should be promoted, as well as of the fact that many (and perhaps most) events begin outside hospitals, so that prevention is at least as important as in-hospital management. Our st udy indicates the importance of primordial prevention; that is, attending to overcrowding and other social determinants of hea lth. Additionally, primary prevention of infections by eviden ce-based, community-driven primary health programs could prevent a range of associated sequelae, and reduce the need for repeated courses of antibiotics in an era of increasing antibiotic resistance. 27 These are important areas for future research, evaluation, and continuous quality improvement.
Limitations
Our study was limited by its retrospective design and the need for a baseline creatinine value from the 7 days preceding the AKI event. We will also have missed events detected during the recovery phase after an initial creatinine rise. The authors of a recent multinational study using a similar KDIGO-based methodolog y noted the same limitation, and modified the criteria to allow measures of baseline renal function that were up to 12 months old, but they commented that this probably led to some instances of progressive CKD being misclassified as AKI. 28 This problem would be particularly relevant in our study population, in which CKD is common. Further, data on urine output, a complementary component of the KDIGO definition of AKI (output less than 0.5 mL/kg/h for at least 6 hours 5 ), were not available for our analysis.
As a result of these limitations, we probably underestimated the number of AKI events. Our results would also be biased toward events diagnosed in hospitals with regular creatinine monitoring. Our data consequently do not provide an accurate estimate of the incidence of AKI, but indicate demographic and aetiological patterns that could be useful for informing clinical practice.
The age distribution and pattern of diagnoses we described is limite d to a particular setting, a relatively remote area with a large Indigenous population in the tropical north of Western Australia. Analysis of data at the regional level can provide useful information for developing policy, but our findings may not be generalisable to other regions. While AKI is a recognised risk factor for CKD, data on the rate of progressive renal dysfunction and mortality are not available. Fewer than one-third of the discharge summaries we reviewed included AKI as a principal or add itional diagnosis, suggesting that AKI is undercoded by hospit al physicians. This has implications for estimating the burden of disease and for communicating to primary care providers that the AKI event is a health risk factor that requires follow-up. If events are not recognised, opportunities for reducing their impact may be missed.
Conclusion
Our study illustrates the utility of the KDIGO criteria for investigati ng AKI at the population level and the benefits of combining the analysis of pathology, hospitalisation, and primary care data sets at the regional level. Further, we highlight a recognise d risk factor for CKD and the opportunity to reduce its impact by reviewing and improving aspects of clinical care for Indigenous Australians in community and hospital settings in the Kimberley and other remote areas of Australia.
